ArticleClinical pharmacology and therapeutics2022

Evaluation of US Food and Drug Administration Drug Label Recommendations for Coadministration of Antivirals and Acid-Reducing Agents.

Tyler Shugg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.